Jensen Investment Management Inc. established long positions in NVIDIA, Eli Lilly, and Meta Platforms in the second quarter. 
Increased holdings in Abbott Laboratories, KLA Corporation, Amphenol, Copart, and IDEXX Laboratories. 
Fully divested from Microchip Technology, Lennox, Marriott International, and Starbucks. 
Reduced holdings in UnitedHealth, Texas Instruments, Accenture, Apple, and PepsiCo. 
Major holdings include Microsoft, Stryker, Marsh McLennan, Intuit, and Apple

Jensen Investment Management Inc. increased its holdings in NVIDIA, Eli Lilly, and Meta Platforms in the second quarter, while also increasing its positions in Abbott Laboratories, Kentech Electronics, Amphenol, Copart, and Idexx Labs. It completely liquidated its positions in Microchip Technology, Lennox, Marriott International, and Starbucks, and reduced its holdings in UnitedHealth, Texas Instruments, Accenture, Apple, and PepsiCo. The major holdings include Microsoft, Stryker, Marsh McLennan, Intuit, and Apple

News